PT-141 is a synthetic cyclic heptapeptide derived from a melanocortin analog and studied in controlled laboratory and in vitro settings for molecular structure, melanocortin receptor interactions, receptor-binding characteristics, and comparative analytical behavior.
Laboratory investigations involving PT-141 may examine interactions with melanocortin receptor subtypes including MC3R and MC4R, receptor affinity, ligand-receptor dynamics, signaling characteristics, and structure-activity relationships under defined experimental conditions.
PT-141 may also serve as a reference material in comparative melanocortin peptide research involving cyclic peptide structure, receptor selectivity, molecular stability, binding characteristics, and analytical reproducibility. These studies focus on experimentally observed molecular and analytical properties rather than physiological, behavioral, clinical, diagnostic, or therapeutic outcomes.
Summary of Characteristics
| Characteristic | Details |
|---|---|
| Chemical Sequence of Amino Acids | Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-OH |
| CAS Number | 189691-06-3 |
| Molecular Formula | C50H68N14O10 |
| Molecular Weight | 1,025.2 g/mol |
| Purity | ≥99%, verified by independent third-party testing |
| Storage | Store lyophilized at -20°C, protected from light and moisture. Once reconstituted, store at 2-8°C and use within the timeframe indicated in the accompanying documentation. Keep the container tightly sealed. |
| Other Known Titles | PT-141 Research Peptide; Melanocortin Receptor-Associated Research Peptide |
